Humana's HUM +1.79% + Free Alerts short percent of float has fallen 14.71% since its last report. The company recently reported that it has 3.12 million shares sold short, which is 2.9% of all regular ...

UNH's troubles are piling up, from a fresh DOJ criminal probe and rising costs to leadership shakeups and pulled guidance.

The market awaits Humana's announcement ... indicating a potential 12.96% upside. This comparison focuses on the analyst ratings and average 1-year price targets of Molina Healthcare, HealthEquity ...

Humana has a P/E ratio of 16.4 based on its 12 month trailing earnings per share of $14.17. Considering its future earnings ...

"The company suspended its 2025 outlook as care activity continued to accelerate while also broadening to more types of benefit offerings than seen in the first quarter, and the medical costs of many ...

Humana (HUM) reported $32.11 billion in revenue ... changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of ...

Shares of Humana Inc. HUM shed 1.51% to $249.53 Friday, on what proved to be an all-around grim trading session for the stock ...

Humana recently announced affirming a cash dividend and restructuring its public offering lead underwriters, setting a financial foundation amid market fluctuations. Over the past month ...

Humana, the second-largest Medicare Advantage insurer with 5.8 million beneficiaries, reported Wednesday that net income soared 67.9% to $1.2 billion in the first quarter as revenue grew 8.4% to $32.1 ...

Can prescription benefit managers, or PBMs, be eliminated from the U.S. drug pricing process? Seeking Alpha analysts weigh in. Read more here.